Larotrectinib for treating NTRK fusion-positive advanced solid tumours: Single Technology Appraisal Evidence Assessment Group report for the Evidence Review Group Report for the National Institute for Health and Care Excellence

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Publication statusPublished - 2020

Cite this